GO	[-10.12 -0.92]	[-0.92 -0.59]	[-0.59 -0.36]	[-0.36 -0.17]	[-0.17 0.00]	[0.00 0.01]	[0.01 0.20]	[0.20 0.42]	[0.42 0.74]	[0.74 1.53]	[1.53 23.61]
NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN	-0.381	0.233	-2.322	-2.322	-0.622	3.432	-2.322	-0.977	-0.622	0.233	7.363
FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP	0.325	-1.593	-1.177	-1.177	-0.418	0.325	-2.847	-0.854	-1.177	1.697	10.897
PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP	-0.610	-1.201	-1.201	-0.610	-1.201	2.463	-1.201	-0.610	0.303	0.303	5.428
FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN	-1.028	-1.553	-0.382	-1.553	0.678	-2.259	-0.647	-0.501	-0.382	4.094	4.836
LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE	-0.434	-0.434	-1.064	-0.434	-2.447	-0.434	-0.434	-1.064	-0.691	5.559	3.170
HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP	-0.678	0.319	-3.703	-2.094	-1.710	0.429	-0.678	0.559	1.071	3.312	2.310
FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP	0.301	-0.580	-2.132	-0.423	-0.580	-0.301	-1.689	-0.778	-0.778	1.942	7.032
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN	-0.668	-0.479	-0.479	-1.595	-0.909	1.430	-1.214	-0.668	-1.214	3.141	3.538
PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP	-0.610	-0.610	-1.201	-1.201	-0.610	1.879	-1.201	-0.610	0.573	0.929	3.104
MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP	-0.566	-0.359	-0.859	-1.855	-0.566	-0.859	-0.566	-0.859	0.848	1.829	4.782
LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP	-0.260	-0.550	-1.118	-1.118	-1.118	1.505	-0.550	-0.550	-0.260	0.645	4.119
FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE	-0.796	-1.346	0.408	-1.043	-1.043	-2.704	0.408	0.292	0.714	3.273	2.199
HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE	-0.300	-1.658	-0.549	-0.300	-1.658	1.596	-0.958	-0.549	0.302	0.528	3.807
MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP	0.290	0.427	-0.918	-2.232	-0.461	-0.659	-0.461	-1.252	0.427	0.595	5.989
GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN	0.784	-0.687	-0.512	-0.903	-2.900	1.440	-0.687	-0.687	-0.903	1.198	3.722
HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN	0.381	-0.828	0.647	-0.828	-1.492	1.862	-0.828	-1.492	0.381	-0.453	2.970
FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP	-0.645	-2.364	-0.645	-0.234	-0.234	-0.234	-2.364	0.380	0.846	1.153	2.813
ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP	-0.764	-1.409	-0.764	-0.764	-0.407	2.013	1.514	-0.764	-0.764	0.216	2.565
HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_UP HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_UP	1.033	-0.260	-1.118	-0.260	0.347	0.347	-1.118	-1.118	-1.118	0.347	3.361
LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE	0.279	-0.787	-0.787	-0.787	0.279	0.279	-0.787	-0.787	1.058	-0.324	3.850
FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_DN FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_DN	-0.764	0.427	-0.407	-0.764	0.216	1.080	-1.409	-1.409	-0.407	0.427	3.861
KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	0.254	-0.354	-0.624	-1.057	-0.624	2.901	-0.624	-1.057	-0.354	-0.624	3.480
LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN	-0.787	0.279	-0.787	-0.787	-0.787	0.609	0.279	0.279	0.609	-0.787	3.013
LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP	-0.363	0.247	-1.326	-0.702	-1.326	1.185	-0.702	-0.363	0.247	1.185	2.171
HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP	-0.351	0.992	-0.828	0.256	-0.828	-0.351	-0.828	-0.351	-0.351	0.256	3.665
